ALGS Market Cap History
Below is a table of the ALGS market cap history going back to 10/16/2020:

Date ALGS Market Cap

Also see: ALGS Shares Outstanding History
and ALGS YTD Return
ALGS Historical Market Cap:
-71.46% CAGR
ALGS Historical Market Cap: +-71.46% CAGR

Mouse over chart for data details
Aligos Therapeutics is a clinical-stage biopharmaceutical company. Co. utilizes its proprietary oligonucleotide and small molecule platforms to develop pharmacologically optimized drug candidates for use in combination regimens designed to achieve improved treatment outcomes. Co. has developed a portfolio of differentiated drug candidates for Chronic Hepatitis B, including a small molecule Capsid Assembly Modulator and oligonucleotides, each of which is designed against clinically validated targets in the Hepatitis B Virus life cycle. Co. is also exploring approaches towards boosting immune response with the use of small molecule antagonists of the PD1/PD-L1 interaction. We show 9 historical shares outstanding datapoints in our ALGS shares outstanding history coverage, used to compute ALGS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALGS market cap history over the course of time is important for investors interested in comparing ALGS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALGS versus a peer is one thing; comparing ALGS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALGS can fluctuate over the course of history. With this page we aim to empower investors researching ALGS by allowing them to research the ALGS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ALGS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aligos Therapeutics (ALGS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ALHC Market Cap History
ALIM Market Cap History
ALKS Market Cap History
ALLK Market Cap History
ALLO Market Cap History
ALNA Market Cap History
ALNY Market Cap History
ALOG Market Cap History
ALPN Market Cap History
ALQA Market Cap History
More Healthcare companies »


ALGS Market Cap History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.